Understanding Participation in Anxiety Clinical Trials
Part of Mental health clinical trials.
This study looks at how people with generalized anxiety disorder (GAD) decide to join or stay in clinical trials. It is an observational study, meaning no new treatment is given—just tracking your participation experiences.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of generalized anxiety disorder (GAD).
- You must be 18 years old or older.
- You must be able to attend scheduled visits and follow the study plan.
- You cannot be pregnant or breastfeeding.
- You cannot be currently taking part in another clinical trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational medication to see if it can reduce anxiety symptoms in adults with generalized anxiety disorder. Participants will receive the study drug and be monitored for safety and effectiveness.
This trial tests whether an already-studied medication, SEP-363856, can continue to safely help adults with generalized anxiety disorder over a longer period. It may offer ongoing symptom relief for people who completed a previous study of this drug.
This study tests a new medicine (SEP-363856) for adults with generalized anxiety disorder to see if it reduces anxiety symptoms and is safe. It may help if other treatments haven't worked well.
This trial tests a new medicine called SYT-510 for adults with generalized anxiety disorder who are not currently taking medication. It aims to see if the drug reduces anxiety and is safe.
This trial compares two short-term therapies—psychoanalytic and cognitive behavioral—for people with generalized anxiety disorder (GAD). It aims to see which approach works better over 12 weekly sessions.
This study tests an investigational oral medication (ITI-1284) for people with moderate to severe generalized anxiety disorder (GAD) who haven't found enough relief from at least two standard medications. The goal is to see if this new drug helps reduce anxiety symptoms.
Hear when a new Generalized Anxiety Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.